Brain enzyme caught doing something unexpected—it builds polysialic acid on itself

The discovery that a well-characterized brain enzyme can synthesize and attach a sugar chain to itself—and then secrete itself in an inactive state—is more than a biochemical curiosity. It challenges long-held assumptions about enzyme function, protein regulation, and the dynamic nature of cellular communication in the brain. Polysialic acid, a linear chain of sialic acid sugars, is typically associated with neural cell adhesion molecules, where it modulates cell migration and synaptic plasticity. But here, an enzyme—known for its role in neurotransmitter metabolism—is shown to be capable of synthesizing this same sugar modification on its own surface. That suggests a far broader and more fluid role for glycoconjugation than previously recognized, one that may extend beyond structural proteins to include enzymes themselves as both substrates and regulators. What makes this finding particularly significant is that it blurs the line between enzyme activity and post-translational modification. Enzymes are traditionally seen as catalysts performing one function, not as self-modifying entities. The fact that this enzyme undergoes auto-glycosylation and then inactivates itself upon secretion implies a built-in feedback mechanism—one that could fine-tune neurotransmitter levels in real time by limiting its own activity through structural change. This could represent a novel form of enzymatic self-regulation, where the protein literally “shuts itself down” by cloaking its active site in sugar. Open questions abound. Does this behavior occur under physiological conditions in the brain, or was it observed only in vitro? Could other enzymes—especially those in the nervous system—possess similar hidden glycosylation capacities? And if so, how might this reshape our understanding of metabolic pathways and signaling networks? The discovery also aligns with a growing recognition that glycobiology is far more dynamic and context-dependent than once thought. As researchers uncover more instances of enzymes modifying themselves or their partners, the once-static view of protein function is giving way to a more fluid, self-organizing model of cellular biochemistry. That shift could have implications not only for neuroscience but for biotechnology and medicine, where enzyme-based therapies might one day be fine-tuned through targeted glycosylation.